Shattuck Labs (STTK) Return on Capital Employed (2020 - 2026)
Shattuck Labs' (STTK) quarterly Return on Capital Employed came in at 57.04% in Q1 2026, up 4051.0% year-on-year from 1.37% in Q1 2025, and up 1.85% on a QoQ basis from 58.12% in Q4 2025.
Shattuck Labs (STTK) Return on Capital Employed (2020 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 7 years of Return on Capital Employed data on file, last reported at 57.04% in Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 4051.0% year-over-year to 57.04% in Q1 2026; TTM through Mar 2026 was 57.04%, a 4051.0% increase from a year earlier, with the FY2025 full-year figure at 61.33%, up 789.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 57.04%, up from 58.12% in the prior quarter.
- Over the last five years, Return on Capital Employed for STTK reached as high as 21.3% in Q1 2022 and fell as low as 99.31% in Q2 2025.
- Historically, Return on Capital Employed has averaged 63.87% across 5 years, with a median of 65.17% in 2024.
- Across the five-year window, Return on Capital Employed plunged 4598 bps in 2023 and surged 4051 bps in 2026, its largest moves.
- Year by year, Return on Capital Employed stood at 54.62% in 2022, then slipped by 26 bps to 68.85% in 2023, then slipped by 27 bps to 87.13% in 2024, then surged by 33 bps to 58.12% in 2025, then climbed by 2 bps to 57.04% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 57.04% in Q1 2026, 58.12% in Q4 2025, and 75.02% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Shattuck Labs | 795.74 Mn | 795.74 Mn | - | -57.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.04% |
| Dec 31, 2025 | -58.12% |
| Sep 30, 2025 | -75.02% |
| Jun 30, 2025 | -99.31% |
| Mar 31, 2025 | -97.55% |
| Dec 31, 2024 | -87.13% |
| Sep 30, 2024 | -74.12% |
| Jun 30, 2024 | -73.95% |
| Mar 31, 2024 | -65.17% |
| Dec 31, 2023 | -68.85% |
| Sep 30, 2023 | -77.08% |
| Jun 30, 2023 | -62.49% |
| Mar 31, 2023 | -57.45% |
| Dec 31, 2022 | -54.62% |
| Sep 30, 2022 | -31.10% |
| Jun 30, 2022 | -25.42% |
| Mar 31, 2022 | -21.30% |
| Dec 31, 2021 | -16.17% |
| Sep 30, 2021 | -22.37% |
| Jun 30, 2021 | -19.28% |